Application of neutrophil/lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
Authors:
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Journal of Cardiology
- Vol. 66 (1) , 9-14
Abstract
No abstract availableKeywords
Funding Information
- Department of Education of Heilongjiang Province (12541428)
This publication has 26 references indexed in Scilit:
- Neutrophil to lymphocyte ratio and cardiovascular diseases: a reviewExpert Review of Cardiovascular Therapy, 2013
- Relation of Neutrophil/Lymphocyte Ratio to Coronary Flow to In-Hospital Major Adverse Cardiac Events in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary InterventionThe American Journal of Cardiology, 2012
- Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patientsInternational Urology and Nephrology, 2012
- Biomarkers in acute myocardial infarctionBMC Medicine, 2010
- Usefulness of an Elevated Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality After Percutaneous Coronary InterventionThe American Journal of Cardiology, 2006
- TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACSEuropean Heart Journal, 2005
- Leukocytes and coronary heart diseaseAtherosclerosis, 2004
- Validation of the Thrombolysis In Myocardial Infarction (TIMI) risk score for unstable angina pectoris and non–ST-elevation myocardial infarction in the TIMI III registryThe American Journal of Cardiology, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment ElevationCirculation, 2000